课题基金 / 基金详情

Development of advanced causal methodology for the evaluation of pharmaceutical safety and effectiveness using electronic medical databases

Development of advanced causal methodology for the evaluation of pharmaceutical safety and effectiveness using electronic medical databases
使用电子医学数据库开发先进的因果方法来评估药物安全性和有效性
批准号：
320072
负责人：
Schnitzer Mireille E
金额：
$21.86万
依托单位：
Universit de Montral
依托单位国家：
加拿大
项目类别：
Salary Programs
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-12-01 至 2019-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=320072&lang=en
关键词：
Causal Inference Comparative Effectiveness Drug Effectiveness Drug Safety Electronic Medical Databases Longitudinal Data Marginal Structural Models Pharmacoepidemiology Propensity Score Targeted Maximum Likelihood

项目摘要

项目成果

Schnitzer Mireille E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
My research goals are to improve the ways in which we statistically estimate the health effects and safety of medication. I use data collected for medication and medical services billing as well as data collected in hospital that are recorded in provincia
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prize 202203PJT - The test-negative design for the estimation of COVID-19 vaccine effectiveness: design evaluation and development of statistical methods in the evolving context
  • 批准号：
    467985
  • 项目类别：
    Operating Grants
  • 资助金额：
    $7.29万
  • 财政年份：
    2022
  • 负责人：
    Schnitzer Mireille E
  • 依托单位：
    Universit de Montral
The test-negative design for the estimation of COVID-19 vaccine effectiveness: design evaluation and development of statistical methods in the evolving context
  • 批准号：
    462230
  • 项目类别：
    Operating Grants
  • 资助金额：
    $20.06万
  • 财政年份：
    2022
  • 负责人：
    Schnitzer Mireille E
  • 依托单位：
    Universit de Montral
Canada Research Chair - Tier 2
  • 批准号：
    404317
  • 项目类别：
  • 资助金额：
    $43.71万
  • 财政年份：
    2018
  • 负责人：
    Schnitzer Mireille E
  • 依托单位：
    Universit de Montral
Evaluating treatment effect heterogeneity and optimal regimens in multidrug resistant tuberculosis using causal inference modeling
海外基金